One of the most underappreciated drivers of poor outcomes in oncology is the progressive nutritional collapse that many patients experience, a syndrome in which tumors and their treatments strip away muscle, drain energy reserves, and undermine the very therapies designed to defeat the disease.
One of the most underappreciated drivers of poor outcomes in oncology is the progressive nutritional collapse that many patients experience, a syndrome in which tumors and their treatments strip away...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
One of the most underappreciated drivers of poor outcomes in oncology is the progressive nutritional collapse that many patients experience, a syndrome in which tumors and their treatments strip away muscle, drain energy reserves, and undermine the very therapies designed to defeat the disease.
One of the most underappreciated drivers of poor outcomes in oncology is the progressive nutritional collapse that many patients experience, a syndrome in which tumors and their treatments strip away muscle, drain energy reserves, and undermine the very therapies designed to defeat the disease.
Open the app view to save this story, compare related coverage, and continue from the same source.